Biofeedback-VR for Treatment of Chronic Migraine
Chronic Migraine, Behavioral Treatment, Biofeedback
About this trial
This is an interventional treatment trial for Chronic Migraine
Eligibility Criteria
Inclusion Criteria: Diagnosis of International Classification of Headache Disorders (ICDH-3 beta) criteria for chronic migraine Individuals having experienced least 15 headache days per month (including at least 8 migraine days per month) in the preceding 3 months Ability to speak English or Spanish Exclusion Criteria: Individuals with cognitive impairment, severe psychiatric comorbidities (including active suicidal or homicidal ideation and/or psychosis), hearing/seeing difficulties, epileptic or non-epileptic seizures, and prisoners.
Sites / Locations
- University of Washington
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Group (Biofeedback-VR intervention plus standard clinical care)
Control Group (standard clinical care alone)
This arm includes individuals with chronic migraine receiving the home-based biofeedback-VR intervention plus standard medical care as treatment for chronic migraine
This arm, a wait-list control group, includes individuals with chronic migraine receiving standard medical care alone as treatment for chronic migraine.